CCK and schizophrenia: Cholecystokinin was found to be unchanged after antipsychotic use in persons with schizophrenia [77], although animal studies showed that antipsychotics could counteract the satiating effect of cholecystokinin [78], and the polymorphism of the cholecystokinin receptor gene was found to be associated with antipsychotic-related weight gain [79].